Clinical Trials Directory

Trials / Completed

CompletedNCT02359604

The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
3 Months – 1 Year
Healthy volunteers
Not accepted

Summary

Proton Pump Inhibitors (PPI) are standard in the therapy of pediatric GERD. In the past it has been hypothesized, that either direct inhibition of bacterial ATPase or elevation of the pH may lead to changes in the intestinal microbiome. Small series published in adults suggest a predominance of streptococci, a possible reason for increased incidences of pneumonia under PPI therapy. Studies in children are yet scarce. This study will include 20 infants. GERD will be verified by 24h-intraluminal impedance monitoring. All patients will have undergone conservative measures prior to initiation of PPI therapy (due to persisting symptoms). Children will receive a commercial PPI for 8 weeks (esomeprazole 1mg/kg/day). Stool samples will be collected before initiation of PPI, under PPI (4 weeks after initiation) and 8 weeks after discontinuing PPI therapy. The intestinal microbiome will be determined by 16S rDNA-based microbial community profiling by high-throughput pyrosequencing. Data will be compared by dependent non parametric test (Wilcoxon). P-values \<0.05 will be considered statistically significant.

Conditions

Interventions

TypeNameDescription
DRUGPPI therapyPPI therapy (medication has FDA approval) for 8 weeks in children with proven GERD. The medication used (esomeprazole) in this trial is approved by the FDA
PROCEDUREStool sampleStool sample will be obtained before initiation of PPI (before PPI therapy)
PROCEDUREStool sampleStool sample will be obtained 4 weeks after initiation of PPI (under PPI therapy)
PROCEDUREStool sampleStool sample will be obtained 8 weeks after termination of PPI therapy (after PPI therapy).

Timeline

Start date
2014-10-01
Primary completion
2017-02-07
Completion
2017-02-07
First posted
2015-02-10
Last updated
2017-02-08

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02359604. Inclusion in this directory is not an endorsement.